IRM
46
5
URI
48
8
APD
47
3
SYY
50
2
DVA
72
2
NEM
53
4
FDX
37
4
DGX
62
5
ZION
55
2
HUM
42
6
MAT
46
3
CHRW
65
5
PYPL
33
2
LLY
54
-3
ECL
45
-2
K
59
3
ZTS
16
4
STX
53
3
CF
44
3
MAR
35
3
IRM
46
5
URI
48
8
APD
47
3
SYY
50
2
DVA
72
2
NEM
53
4
FDX
37
4
DGX
62
5
ZION
55
2
HUM
42
6
MAT
46
3
CHRW
65
5
PYPL
33
2
LLY
54
-3
ECL
45
-2
K
59
3
ZTS
16
4
STX
53
3
CF
44
3
MAR
35
3
Financhill
Back

Range Cancer Therapeutics ETF Vs. Strategy Industry Stock Comparison

Sell
15

CNCR
Range Cancer Therapeutics ETF

Last Price:
$11.14
Seasonality Move:
-1.76%
Buy
52

MSTR
Strategy

Last Price:
$283.26
Seasonality Move:
-5.49%
Sell
15
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $10.83. The Score for CNCR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
52
Strategy (MSTR) is a Buy

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $294.27. The Score for MSTR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MSTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $10.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $294.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 38.79 Sell
Chaikin Money Flow: 423 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.92 - 12.36) Sell
Bollinger Bands (100): (11.65 - 14.43) Sell

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.38 Sell
Relative Strength Index (14 RSI): 50.53 Buy
Chaikin Money Flow: 8661825 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (264.27 - 326.63) Sell
Bollinger Bands (100): (266.3 - 382.96) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.9 Sell
20-day SMA: 11.5 Sell
50-day SMA: 11.96 Sell
200-day SMA: 13.83 Sell
8-day EMA: 10.91 Sell
20-day EMA: 11.31 Sell
50-day EMA: 11.96 Sell
200-day EMA: 13.35 Sell

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 284.75 Buy
20-day SMA: 287.61 Buy
50-day SMA: 320.37 Sell
200-day SMA: 237.74 Buy
8-day EMA: 282.26 Buy
20-day EMA: 290.16 Buy
50-day EMA: 308.43 Sell
200-day EMA: 252.4 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):